Fragile X Syndrome Clinical Trials

120 clinical trials for Fragile X Syndrome across international registries, including 19 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM) — RECRUITING · PHASE2
• The Neurocognitive Bases of Trust in Intellectual Disability — RECRUITING
• Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders — RECRUITING · PHASE2
• Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X Syndrome — RECRUITING · PHASE2
• Parent and Infant Inter(X)Action Intervention (PIXI) — RECRUITING · NA
• Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG- Infant — RECRUITING · NA
• Optical Imaging in X-linked Disorders. — RECRUITING · NA
• Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders — RECRUITING
• Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders — RECRUITING · NA
• Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders — RECRUITING
• Speech-in-noise Perception in Autism and Fragile X — RECRUITING · NA
• The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome — RECRUITING · PHASE4
• Physical Activity and Community EmPOWERment Project — RECRUITING · NA
• Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities — RECRUITING · PHASE1
• Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG-Preschool Age — RECRUITING · NA
• Metformin in Children With Fragile X Syndrome — RECRUITING · PHASE4
• Group CBT in Adolescents With Fragile X Syndrome and in Adolescents With Autism Spectrum Disorder — RECRUITING · NA
• A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF METFORMIN IN INDIVIDUALS WITH FRAGILE X SYNDROME (FXS — RECRUITING
• OPEN STUDY TO EVALUATE THE EFFICACY AND SAFETY OF METFORMIN IN INDIVIDUALS WITH FRAGILE X SYNDROME — RECRUITING
• A study of the efficacy and safety of RO4917523 in patients with Fragile X Syndrome — COMPLETED · PHASE2
• Clinical trial to evaluate ascorbic acid (vitamin C) and tocopherol (vitamin E) in combination versus placebo for the treatment of cognitive and behavioral disorders in children with fragile x syndrome — COMPLETED · PHASE3
• Long-term, safety and tolerability study of AFQ056 in adolescent patients with Fragile X Syndrome (Open–label) — TERMINATED · PHASE2
• Safety and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome — COMPLETED · PHASE2
• Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of MRM-3379 in Male Participants with Fragile X Syndrome — NOT_YET_RECRUITING · PHASE2
• Web Intervention for Parents of Youth With Genetic Syndromes (WINGS) — ACTIVE_NOT_RECRUITING · NA
• A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome — COMPLETED · PHASE3
• Early Check: Expanded Screening in Newborns — ACTIVE_NOT_RECRUITING
• Evaluation of the safety, tolerability, and effectiveness of CTH120 in adult males with Fragile X syndrome — TERMINATED · PHASE2
• Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS — ACTIVE_NOT_RECRUITING · PHASE2
• Study of SPG601 in Adult Men With Fragile X Syndrome — COMPLETED · PHASE2
• A Study to Investigate the Effects and Safety of SPG601 for the Treatment of Fragile X Syndrome in Male Participants — NOT_YET_RECRUITING · PHASE2
• A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome — COMPLETED · PHASE2
• A Trial of Metformin in Individuals With Fragile X Syndrome (Met) — COMPLETED · PHASE2
• Glutaminergic Transmission in Autism : Molecular Imaging Exploration — COMPLETED · PHASE1
• Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge — ACTIVE_NOT_RECRUITING · PHASE2
• Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS) — COMPLETED · PHASE2
• Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome — COMPLETED · PHASE3
• Pediatric Patients With Metabolic or Other Genetic Disorders — COMPLETED
• An Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of ZYN002 Administered as a Transdermal Gel to Children, Adolescents and Young Adults with Fragile X Syndrome — OTHER · PHASE3
• An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome — ACTIVE_NOT_RECRUITING · PHASE3
• A Randomized, Double-Blind, Placebo-Controlled Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children, Adolescents, and Young Adults with Fragile X Syndrome - RECONNECT — OTHER · PHASE3
• Neural Biomarkers in Fragile X Syndrome — COMPLETED
• Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals with Fragile-X Syndrome — NOT_YET_RECRUITING · PHASE2
• Effect of CBD on the Brain — NOT_YET_RECRUITING · PHASE2
• CTH120 First-in-Human Study: Single and Multiple Ascending Doses and Potential Food Interaction — COMPLETED · PHASE1
• A Trial of Metformin in Individuals With Fragile X Syndrome — COMPLETED · PHASE2
• A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome — COMPLETED · PHASE2
• Protein Synthesis in the Brain of Patients With Fragile X Syndrome — COMPLETED
• ERG/5-HTP in Fragile X Syndrome (FXS) — COMPLETED · PHASE2
• A study to learn how safe KER-0193 is, the activity of KER-0193 in the body over a period of time, and the effect of KER-0193 to the body in adult healthy people taking single and multiple doses by the mouth that are increased a little at a time — OTHER · PHASE1

Refine this search